Health · GB ·

ESMO: Amgen’s Imdelltra drives massive survival benefit in ‘watershed moment’ for small cell lung cancer

Fierce Pharma · Health

Published

ESMO: Amgen’s Imdelltra drives massive survival benefit in ‘watershed moment’ for small cell lung cancer

Read it at the source

Fierce Pharma↗

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now